Generic diabetes drug put to the test
NCT ID NCT07479108
Summary
This study tested whether a new generic version of the diabetes medication empagliflozin works the same way in the body as the original brand-name drug, Jardiance. Thirty-two healthy adults took both versions at different times so researchers could compare how the drugs were absorbed and processed. The goal was to see if the generic version is bioequivalent, meaning it delivers the same amount of medicine to the bloodstream as the original.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FS Scientia Pharma
San Luis Potosí City, San Luis Potosí, 78270, Mexico
Conditions
Explore the condition pages connected to this study.